Sun Pharma Advanced Research Company Ltd. — Call Transcript 2024

Jan 3, 2024

SPARC/Sec/SE/2023-24/072

January 03, 2024

National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051.

Scrip Symbol: SPARC

BSE Limited, Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 532872

Dear Sir/Madam,

Sub: SPARC to provide update on Vodobatinib Parkinson’s Disease program

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company would like to provide an update on Vodobatinib Parkinson’s Disease program and in this connection an Investor Call has been scheduled on Saturday, January 6, 2024 at 5.00 pm.

This conference call will be reachable through an audio dial-in.

Audio conference Participants can dial-in on the number below: Universal Dial In +91 22 6280 1278 +91 22 7115 8179 India National Toll Free 1800 120 1221 International Toll Free Hong Kong 800964448 Singapore 8001012045 UK 08081011573 USA 18667462133

To participate in the conference call, please dial in the number provided above couple of minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call.

This is for your information and dissemination.

Yours faithfully,

For Sun Pharma Advanced Research Company Ltd.

Digitally signed by KAJAL DAMANIA KAJAL DN: cn=KAJAL DAMANIA, o=SPIL.COM, ou=SPIL, email=kajal.damania@sparc DAMANIA mail.com, c=IN Date: 2024.01.03 22:44:28 +05'30'

Kajal Damania Company Secretary and Compliance Officer